Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
121.48
+0.61 (0.50%)
Apr 24, 2026, 4:00 PM EDT - Market closed
← View all transcripts

AGM 2018

May 31, 2018

Speaker 1

Good morning, and welcome to the 2018 Annual Meeting of Stockholders of Glaukos Corporation. Please note that this event is being webcast. I would now like to turn the conference call over to Doctor. William Link, Chairman of the Board of Directors of Glaukos Corporation. Doctor.

Link, please go ahead.

Speaker 2

Good morning, everyone. I am William Link, Chairman of the Board of Directors of Glaukos Corporation, and it is my pleasure to welcome you to our 2018 Annual Meeting of Stockholders. I will act as chair for the meeting and I now call the meeting to order. We are hosting this annual meeting virtually over the Internet. A virtual meeting is an annual meeting that takes place exclusively via Internet webcast and we believe that through this online platform, we can increase stockholder access and participation.

I would now like to turn the meeting over to Robert Davis, Senior Vice President, General Counsel and Secretary of Glaukos Corporation for some brief procedural announcements.

Speaker 3

Thank you, Bill. Good morning and welcome everyone. The agenda and rules for conduct for today's meeting are available for viewing on your screen during the web cast. Stockholders who desire to ask a question during the meeting may do so by presenting the question in writing where indicated on the webcast portal for this meeting. We will be happy to respond to appropriate questions about proposals being voted on today after all the proposals are presented before the meeting.

We will also conduct a brief question and answer session at the end of the meeting if stockholders have any business related questions. Please note that only stockholders will be permitted to ask questions and out of consideration for others, please limit yourself to one question. Finally, please note that this meeting is being officially recorded. For that reason, no one attending via the webcast or telephone is permitted to use any audio recording device.

Speaker 2

Thank you. At this time, I'd like to introduce the members of the company's Board of Directors who are present or otherwise participating on the call today. In addition to myself, they are Tom Burns, who is also our President and Chief Executive Officer Mark Foley, David Hoffmeister, Doctor. Gilbert Kleinman, Mark Stapley and Amy Wiesner. I would also like to introduce the company's executive officers who are present on the call today.

I've already introduced to you Tom Burns, our President and Chief Executive Officer and Robert Davis, our Senior Vice President, General Counsel and Secretary. Also present on the call today are Joe Gilliam, our Chief Financial Officer and Senior Vice President of Corporate Development Chris Calcaterra, Chief Operating Officer of the company and Chris Lewis, Director, Investor Relations and Corporate Strategy and Development. Also in attendance at today's meeting is Mary Garrett, a partner at the accounting firm of Ernst and Young, our independent registered public accounting firm. She will be available during the question and answer period to respond to appropriate questions. In addition, I would like to introduce Aubrey Foote, a representative of Broadridge Financial Solutions, who has been appointed as Inspector of Elections and will tabulate the voting results for today's meeting.

Mr. Davis is serving as Secretary for the Annual Meeting. Mr. Davis, would you please report on mailing of the notice for the annual meeting, the number of shares represented at the meeting and whether a forum is present?

Speaker 3

I hereby present an affidavit of Broadridge Financial Solutions, the testing that notice of today's annual meeting was made available to all stockholders of record of Glaukos Corporation commencing on April 18, 2018. The affidavit will be included within minutes of this meeting. On the record date of April 5, 2018, there were 34,826,521 shares of common stock outstanding and entitled to vote at this meeting. I'm advised by the Inspector of Elections that stockholders holding at least 50% of the outstanding shares of common stock entitled to vote are present at this meeting in person or represented by proxy. A quorum is therefore present and business is authorized to be transacted at this meeting.

Speaker 2

Thank you. I will now proceed with the formal business of the meeting. There are 4 items of business to be considered and voted on by stockholders. The first item of business is the election of 3 Class III directors to serve a term that expires at the company's 2021 Annual Meeting of Shareholders and until their represented successors are duly elected and qualified. The Board of Directors nominees are Tom Burns, Doctor.

Gilbert Kleinman and Mark Stapley. Because no other nominations were received in accordance with the advanced notice provisions of Glaukos bylaws, all nominations are now closed. The Board of Directors recommends a vote for all of the Director nominees. The second item of business is the proposal to approve on an advisory basis the compensation of the company's named executive officers as described in the proxy statement. As further described in the proxy statement, we are asking stockholders to vote on the following resolution: Resolve that the company's stockholders approve on an advisory basis the compensation of the company's named executive officers as set forth under executive compensation, including the compensation discussion and analysis, summary of compensation table and the related compensation tables and narrative disclosure in the proxy statement for the 2018 Annual Meeting of Stockholders.

The Board of Directors recommends a vote for the approval on an advisory basis of the compensation of the company's named executive officers. The 3rd item of business is the proposal to approve on an advisory basis the frequency of future advisory votes on executive compensation. The Board of Directors recommends a vote for 1 year with respect to the frequency of future advisory votes on executive compensation. The 4th and final item of business is the proposal to ratify the appointment of Ernst and Young to serve as Glaukos' independent registered public accounting firm for the year ending December 31, 2018. The Board of Directors recommends a vote for the ratification of the appointment

Speaker 1

the

Speaker 2

The polls are now open and we will now vote on the proposals. The voting today is by proxy and electronic ballot. If you have already submitted a proxy by telephone, Internet or mail and do not wish to change your vote, you do not need to do anything else at this time. Any stockholder who hasn't yet voted or wishes to change his or her vote may do so by clicking on the Vote Here button on the webcast portal and following the instructions. If you have not yet submitted a proxy or electronic ballot, you must submit your electronic ballot now in order for your vote to be counted by the Inspector of Elections.

We will leave the polls open for a few moments to allow anyone who chooses to vote electronically to cast their ballots. Now that everyone has had the opportunity to vote, I now declare the polls closed. Ms. Foote, the Inspector of Elections, will now report on the preliminary voting results. Ms.

Foote?

Speaker 4

With respect to Proposal 1, Mr. Burns, Doctor. Kleinman and Mr. Stapley each received a plurality of the votes cast on the proposal at today's Annual Meeting, representing the majority of the shares of common stock present or represented by proxy and entitled to vote on the proposal. With respect to Proposal 2, stockholders holding the majority of the shares of common stock present or represented by proxy and entitled to vote on the proposal at today's meeting, voted for the approval on an advisory basis of the compensation of the company's named executive officers.

With respect to Proposal 3, stockholders holding the majority of shares of common stock present or represented by proxy and entitled to vote on proposal at today's annual meeting voted for 1 year with respect to the frequency of future advisory votes on executive compensation. With respect to proposal 4, stockholders holding the majority of shares of common stock present or represented by proxy and entitled to vote on proposal at today's annual meeting voted for the ratification of the appointment of Ernst and Young LLP as the company's independent registered public accounting firm for fiscal year 2018.

Speaker 2

Thank you, Ms. Foote. Based on the results tabulated by the Inspector of Elections, the vote shows that the stockholders have elected each of Mr. Burns, Doctor. Kliman, Mr.

Staffly as Class III Directors for a term expiring at the 2021 Annual Meeting of the stockholders and until his or her respective successor has been duly elected and qualified. Approved on an advisory basis, the compensation of Glaukos' named executive officers, approved 1 year as the frequency of future advisory votes on executive compensation and ratified the appointment of Ernst and Young as Glaukos' independent registered public accounting firm for fiscal 2018. The final results of the vote today will be reported in a Form 8 ks to be filed with the Securities and Exchange Commission within the next 4 business days. Ladies and gentlemen, that concludes our planned agenda. There is no other formal business before the meeting today and I now declare the meeting adjourned.

Speaker 5

Okay. Hi. I'm Joe Gilliam, Chief Financial Officer of Glaukos Corporation. Thank you for participating today in our annual meeting. We would now welcome questions from our stockholders about other matters relating to our business.

With us for the Q and A are Tom Burns, our President and Chief Executive Officer Chris Calcutera, our Chief Operating Officer and myself. So that we may answer questions from as many stockholders as possible, we request stockholders only ask one question so that others may have an opportunity to ask their questions. Before we begin, I would like to note that our responses to your questions today may include forward looking statements. Our actual results may differ materially from those projected in these statements. Please review the Risk Factors section included in our most recent quarterly report on Form 10 Q filed with the Securities and Exchange Commission for a discussion of factors that may cause actual results to differ from those projected in the forward looking statements.

Okay. There appear to be no questions at this time. So the question and answer period is now concluded. Thank you for joining us today.

Speaker 1

Ladies and gentlemen, that does conclude today's conference. You may now disconnect your lines. Thank you.

Powered by